In conclusion, our study suggests that several serum cytokine levels, including IL-6, IL-5, IL-8, TNF-α, IL-10, and IL-4, could serve as prognostic indicators in NSCLC patients receiving chemotherapy and PD-1 inhibitor-based treatment. The gene discussed is TNF; the disease is non-small cell lung carcinoma.